Answers are grounded in this paper and cite their sources.
Eosinophil-derived COX-2 protects intestinal barrier in colitis, indicating its role in IBD therapy.
as a critical regulator of IL-22 production during colitis, uncovering a eosinophil-ILC3 cross talk that safeguards the intestinal barrier and represents a promising therapeutic target in IBD.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: